Open access · CC-BY
via OpenAlex
Epigenetic aging biomarkers in dietary geroscience: feasibility, participant perceptions, and trial design considerations
Lindsay M. Reynolds, TIMOTHY D. HOWARD, Carl D. Langefeld, Mara Z. Vitolins
GeroScience · 2026 · ▲ 1 citations
Abstract
Abstract Targeting biological processes of aging is a central goal of geroscience; however, limited data exist regarding the feasibility of incorporating biological aging biomarkers into dietary intervention trials. We conducted a pilot feasibility study among 34 adults aged 48–81 years with metabolic syndrome, a condition associated with elevated risk of age-related cardiometabolic disease and advanced biological aging. Participants consumed 1 oz of tree nuts and two tablespoons of extra virgin olive oil daily for 4 weeks. The primary objectives were to evaluate feasibility, adherence, and participant acceptability of epigenetic aging assessments. Exploratory outcomes included DunedinPACE, a measure of the pace of aging, and AgeAccelGrim, a measure of biological age relative to chronological age. At baseline, all participants exhibited a faster pace of biological aging than average as assessed by DunedinPACE, supporting metabolic syndrome as a promising target population for geroscience interventions. Adherence to the dietary intervention exceeded 95%, and most participants reported willingness to participate in a similar longer-term trial. Participants expressed a strong interest in learning their biological age and indicated that evidence of slowed aging would motivate sustained dietary change. No significant changes in epigenetic aging were observed over the 4-week intervention. These findings demonstrate the feasibility and acceptability of incorporating epigenetic aging biomarkers into dietary intervention research and suggest that biological aging measures may serve not only as surrogate outcomes but also as tools to support participant engagement. The results also support metabolic syndrome as a relevant population for dietary geroscience trials and provide practical guidance for designing longer-term studies evaluating whether dietary interventions can slow biological aging and promote healthy longevity. ClinicalTrials.gov Identifier: NCT04361617 (date of registration: 04-23-2020)
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s11357-026-02443-0
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Reynolds, L.M., HOWARD, T.D., Langefeld, C.D., & Vitolins, M.Z. (2026). Epigenetic aging biomarkers in dietary geroscience: feasibility, participant perceptions, and trial design considerations. <em>GeroScience</em>. https://doi.org/10.1007/s11357-026-02443-0
Vancouver
Reynolds LM, HOWARD TD, Langefeld CD, Vitolins MZ. Epigenetic aging biomarkers in dietary geroscience: feasibility, participant perceptions, and trial design considerations. GeroScience. 2026. doi:10.1007/s11357-026-02443-0.
BibTeX
@article{lindsay2026Epigen,
title = {Epigenetic aging biomarkers in dietary geroscience: feasibility, participant perceptions, and trial design considerations},
author = {Lindsay M. Reynolds and TIMOTHY D. HOWARD and Carl D. Langefeld and Mara Z. Vitolins},
journal = {GeroScience},
year = {2026},
doi = {10.1007/s11357-026-02443-0},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current developments in nutrition 2026
Open access · OA
Clinical Protocol for the Dietary Approaches to Longevity and Health (DiAL Health) Pilot Trial.
Briefings in Bioinformatics 2022
Preprint · OA
Evaluation of different computational methods for DNA methylation-based biological age
Taipei Medical University Hospital 2024
Open access · US-GOV
The Effects of a Health Literacy-Based Multifactorial Intervention for Middle-Aged and Older Adults With Sarcopenia
The Research of Medical Science Review 2026
Open access · CC-BY
GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL
The Research of Medical Science Review 2026
Open access · CC-BY
GENETIC CLOCKS IN AGING: NOVEL THERAPEUTIC APPROACHES TO DELAY BIOLOGICAL AGING — A RANDOMIZED CLINICAL TRIAL
Danone Asia Pacific Holdings Pte, Ltd. 2026
Open access · US-GOV